Click/Tap a chapter title to enter
| IV.1 | Regulatory Considerations for Drug Development |
| Christiane Chène PhD and Hendrik T Tevaearai MD EMBA | |
| IV.2 | Translational Pathway for Drug Development |
| Hendrik T Tevaearai MD EMBA, Sarah L Longnus PhD, André Roland MSc, Florian Dick MD, Olaf Stanger MD, Didier Locca MD and Christiane Chène PhD |
|
| IV.3 | Personalized Medicine and Translational Genomics |
| Robert Roberts MD |
